Delivered with expertise and empathy

PANTHERx makes rare disease care more hyper-personalized and less overwhelming by focusing relentlessly on each patient and each therapy.

Our continuously improving RxARECARE® model—powered by our SWFT® technology platform—delivers individualized, proactive, and empathetic engagement across the entire patient journey.

PANTHERx experts develop deep personal relationships with patients, prescribers, and our manufacturer partners, serving as trusted advocates to ensure seamless collaboration and exceptional care. Our pharmacists, care coordinators, and other experts talk to our patients, their caregivers, and prescribers regularly to ensure that the treatments, care, and services we deliver are more personal and less overwhelming.

Why "Rare" is Rare

Codified under the Orphan Drug Act of 1983, a disease is considered “rare” if it affects fewer than 200,000 people in the United States.

Over 10,000 rare diseases collectively impact
over 30 million people in the U.S.

95% of rare diseases do not currently have an 
FDA-approved treatment.

blank

News & Insights

How Fragmentation Delays Rare Disease Therapy Access | Pharmaceutical Commerce
Live from Asembia AXS26, Austin Russian explains how access to rare disease treatments can be delayed....
From Hope to Access: Three Lessons From the Front Lines of Rare Disease Launches

By Katie DiLorenzo, PharmD, SVP, Patient and Pharmacy Services and Austin Russian, PharmD, SVP, Program Excellence...

PANTHERx® Rare Pharmacy Earns 2026 MMIT Patient Choice Award for Patient Satisfaction

PITTSBURGH – PANTHERx® Rare, the trusted leader and innovator in patient access and support services for...